The dark consequences of drug shortages
Tackling the rise in illegal online pharmacies caused by drug shortages, how Covid-19 vaccine pricing varies between countries and companies, digitising the supply chain, and more.
Read More
Pharma Technology Focus Magazine
Pharma Technology Focus is free to read on all devices.
Subscribe to Pharma Technology Focus and never miss an issue
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. Produced by a team of experienced editors and contributors, this monthly magazine brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insiders’ views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry…
The ethics of vaccine boosters
The ethical dilemma of vaccine boosters, optimising real-world data in the pharma industry, billionaires search for ways to cure ageing, predicting the placebo response, and much more.
Read More
Unpacking innovation in biologics
Unpacking the challenge of complex biologics, using bacteria to fight breast cancer, fighting Covid-19 with llama-derived antibodies, securing the US pharma supply chain, and much more.
Read More
Once more unto the (data) breach
Cyberattacks to know and learn from, addressing pharmaceutical pollution in European hospitals, the therapeutics treating alcohol use disorder, pushing for a genomics revolution in the UK, and much more.
Read More
Waive goodbye to vaccine patents
Waiving Covid-19 vaccine patents to speed up vaccination efforts, chickenpox vaccines in the UK, algae proteins spotlight innovation in ophthalmology, fighting black fungus in India, and much more.
Read MoreWhether you want to increase brand awareness, deliver a complex message or launch a new product, our online magazine provides a creative medium to communicate effectively with your audience…
Reach your audience
Delivered directly to 50,000 industry professionals inboxes and be seen by our online community of 45,000 visitors every month.
Rich digital content
Enables you to provide innovative content and features to engage your reader more with your brand.
Editorial focused advertorial content
Giving you the opportunity to communicate a more detailed message.
We offer one of the most varied and competitive price plans available today. Select from an array of creative and flexible solutions across a range of media to meet your specific needs.
Full Page Advertisements
A full page advertisement that fills the screen of all readers of the online magazine is a fantastic way to improve customer loyalty and build a stronger brand with strong visual images, text and embedded links.
Furthermore, you can enhance this advertisement with both animation and video, to further excite and engage our readership.
Advertorial Content
Our online magazines also offer the unique opportunity for you to utilise the most effective mechanism for delivering dynamic, creative and in-depth content. Our advertorial content opportunities offer you to chance to work directly with our editorial team to create the perfect combination of company or product overview and brand promotion delivered to our users in the power-technology.com house style they know and trust.
Testimonials
“We at Bürkert chose to work with Pharma Technology Focus online magazine because we find it to be a very innovative tool, not only as regards the stunning design but also elements such as interesting animations, videos and interactive images.
We also appreciate the monthly in-depth focus on a particular pharmaceutical industry area. Last but not least, working with the people from Pharma Technology Focus has always been great as we have found them to be very patient, accommodating and friendly, even when we were a little late with submitting our materials. Altogether, we consider PTF an excellent tool for promoting our brand within the pharmaceutical industry.”
Bürkert
